Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Axogen (AXGN) Research & Development (2016 - 2026)

Axogen has reported Research & Development over the past 17 years, most recently at $7.5 million for Q1 2026.

  • For Q1 2026, Research & Development rose 23.41% year-over-year to $7.5 million; the TTM value through Mar 2026 reached $34.3 million, up 29.73%, while the annual FY2025 figure was $32.9 million, 18.43% up from the prior year.
  • Research & Development for Q1 2026 was $7.5 million at Axogen, down from $12.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $12.4 million in Q4 2025 and troughed at $5.3 million in Q4 2022.
  • A 5-year average of $7.1 million and a median of $7.0 million in 2024 define the central range for Research & Development.
  • On a YoY basis, Research & Development climbed as much as 84.61% in 2025 and fell as far as 17.79% in 2025.
  • Year by year, Research & Development stood at $5.3 million in 2022, then soared by 35.89% to $7.2 million in 2023, then dropped by 6.56% to $6.7 million in 2024, then surged by 84.61% to $12.4 million in 2025, then tumbled by 39.26% to $7.5 million in 2026.
  • Business Quant data shows Research & Development for AXGN at $7.5 million in Q1 2026, $12.4 million in Q4 2025, and $7.6 million in Q3 2025.